Skip to main content
. 2014 Sep 10;4:34–41. doi: 10.1016/j.rinphs.2014.09.001

Fig. 5.

Fig. 5

The influence of excipients of formulations F1–F8 (a) area under the plasma concentration-time curve (AUClast) (b) concentration at time zero (C0) (c) plasma half-lives (t1/2).